Interferon-α potentiates the antiproliferative activity of CPT-11 against human colon cancer xenografts in nude mice

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2677-2680

  Kobayashi, Isao ^a   Ohwada, Susumu ^a   Maemura, Michio ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Colon cancer; CPT 11; Recombinant human interferon alpha

Indexed keywords

ALPHA INTERFERON; IRINOTECAN; RECOMBINANT ALPHA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CELL CYCLE; CELL CYCLE S PHASE; COLON CANCER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; HUMANS; INTERFERON TYPE I, RECOMBINANT; MICE; MICE, INBRED BALB C; MICE, NUDE; TUMOR CELLS, CULTURED;

EID: 0029859259     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wall ME. Wani MC and Cook CE: Plant antitumor agents: 1. The isolation and structure of Camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 88: 3888-3890, 1966.
2. Hsiang Y. Hertzherg R and Hecht S: Camptothecin induces protein-linked DNA breakage via mammalian DNA topoisomerase 1. J Biol Chem 260: 14873-14878, 1985.
3. Kawato Y, Furuta T, Aonuma M, Yasuoka M, Yokokura T and Matsumoto K: Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother Pharmacol 28: 192-198, 1991.
4. Stefano C, Elena DF and Anna F: Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations. Cancer Res 53: 5429-5432, 1993.
5. Onishi T, Machida T and Hagiwara H: The effects of CPT-11 in combination with tumor necrosis factor or interferon against human renal cell carcinoma heterotransplanted in nude mice. Biotherapy 5: 403-407, 1991.
6. Elias L and Sandoval JM: Interferon effects upon fluorouracil metabolism by HL-60 cells. Biochem Biophys Res Comm 163: 867-874, 1989.
7. Je J, Prensky AW and Yip YK: Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 131: 2821-2826, 1983.
8. Naomoto Y, Tanaka N and Orita K: Antitumor effect of natural human tumor necrosis factor-α and natural human interferon-α in combination against human cancer transplanted into nude mice. Acta Med Okayama 43: 211-221, 1989.
9. Wadler S, Wersto R and Weinberg V: Interaction of fluorouracil and interferon in human colon cancer cell lines: Cytotoxic and cytokinetic effects. Cancer Res 50: 5735-5739, 1990.
10. Creasey AA, Bartholomew JC and Merigan TC: Role of G0/G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci USA 77: 1471-1475, 1980.
11. Lundblad D and Lundgren E: Block of a glioma cell line in S by interferon. Int J Cancer 27: 749-754, 1981.
12. Kondo H, Tanaka N, Naomoto Y and Orita K: Combined effect of human recombinant interferon α, β, γ on tumor cell growth and cell cycle in vitro. Jpn J Cancer Chemother 14: 1234-1239, 1987.
13. Susan BH and Marshall SH: Effect of Camptothecin on the breakage and repair of DNA during the cell cycle. Cancer Res 33: 2834-2836, 1973.
14. Robert CG, Jacqueline WP and Richard HA: Studies on the antitumor activity, mechanism of action, and cell cycle effects of Camptothecin. J Natl Cancer Inst 46: 789-795, 1971.